Figure 4.
Overangiogenic response and lack of inhibitory SEMA3A induction in VEGF-treated MMECs compared with MGECs and HUVECs. (A) Mitogenic and chemotactic response to VEGF165 by MMECs, compared with MGECs and HUVECs. Parallel expression of VEGF165, SEMA3A, and NRP1 production at mRNA (B) and protein (C) level by the indicated ECs at different times of VEGF165 stimulation.